Latest Security News

G11 Resources has announced a maiden Exploration Target at its Wilandra Copper Project in NSW and a conditional acquisition of Pacific State Metals, expanding its copper and gold portfolio significantly.

DGR Global Limited’s Q3 2025 report reveals ongoing project development, strategic equity holdings, and complex legal proceedings shaping its resource company creation model.

Catalyst Metals has doubled its Plutonic Gold Belt reserves to 1.5 million ounces, setting the stage to double annual gold production to 200,000 ounces over the next decade. The company’s strategic mine developments and exploration programs underpin a confident growth trajectory.

Atlantic Lithium has finalized revised fiscal terms with the Ghanaian government for its Ewoyaa Lithium Project and awaits parliamentary ratification, while reporting strong exploration results in Côte d’Ivoire and securing significant funding agreements.

Admiralty Resources NL reported a mixed cash flow quarter ending September 2025, balancing operating outflows with investing and financing inflows to maintain a solid funding runway.

Admiralty Resources NL reported steady production growth at its Mariposa Iron Ore Project in Chile, securing key export approvals and infrastructure progress despite a delay in its audited financial statements that led to ASX suspension.

Gateway Mining has completed its acquisition of the Yandal Gold Project, revealing promising high-grade gold results and securing $22.5 million to fuel extensive exploration and drilling programs.

Adherium Limited reports a strong quarter with a 55% increase in device shipments and groundbreaking clinical results from its iCARE study, alongside securing over $2.6 million in post-quarter funding.

Zuleika Gold advances its Plutonic Mine litigation with a trial delay to early 2026, while gearing up for exploration drilling and bolstering its finances with new funding.

Legacy Minerals reports multiple high-priority exploration targets at Mt Carrington with drilling underway and a metallurgical study initiated, alongside encouraging assay results at Thomson and a major PGE drill campaign at Fontenoy.

Chimeric Therapeutics has progressed its CHM CDH17 and CHM CORE-NK clinical trials with promising safety and efficacy signals, while securing a key manufacturing partnership and appointing a renowned haematologist to its board. However, the company faces a pressing cash runway challenge.

Adavale Resources has reported significant gold mineralisation extending beyond current estimates at its London Victoria Gold Mine, alongside securing $3.1 million in funding and appointing David Ward as Managing Director.